JP2009539846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009539846A5 JP2009539846A5 JP2009514368A JP2009514368A JP2009539846A5 JP 2009539846 A5 JP2009539846 A5 JP 2009539846A5 JP 2009514368 A JP2009514368 A JP 2009514368A JP 2009514368 A JP2009514368 A JP 2009514368A JP 2009539846 A5 JP2009539846 A5 JP 2009539846A5
- Authority
- JP
- Japan
- Prior art keywords
- hemi
- compound
- tartrate salt
- crystalline form
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
- 形態N-3を含む、化合物Iのヘミ-L-酒石酸塩の結晶形
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81148206P | 2006-06-06 | 2006-06-06 | |
| PCT/US2007/013384 WO2007146039A2 (en) | 2006-06-06 | 2007-06-06 | Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009539846A JP2009539846A (ja) | 2009-11-19 |
| JP2009539846A5 true JP2009539846A5 (ja) | 2010-07-29 |
Family
ID=38668926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009514368A Pending JP2009539846A (ja) | 2006-06-06 | 2007-06-06 | Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2044066A2 (ja) |
| JP (1) | JP2009539846A (ja) |
| WO (1) | WO2007146039A2 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008036954A1 (en) * | 2006-09-21 | 2008-03-27 | Sunesis Pharmaceuticals, Inc. | Use of n- [5- [ [ [5- (1, 1-dimethylethyl) -2-oxazoyl] methyl] thio] -2-thiazolyl] -4-piperidinecarboxamide |
| KR101643280B1 (ko) * | 2014-09-02 | 2016-07-28 | 한국원자력의학원 | 항암 효과, 방사선 병용치료 효과 및 당뇨병 치료 효과를 갖는 피페리딘카복사마이드 유도체 및 이의 의학적 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3588363B2 (ja) * | 1997-02-27 | 2004-11-10 | ファイザー・インク | キノキサリンジオン類 |
| GB9711127D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| US6262096B1 (en) * | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
| US6414156B2 (en) * | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
| WO2001010824A1 (de) * | 1999-08-10 | 2001-02-15 | Lonza Ag | Dicyanatochalkone und verfahren zu deren herstellung |
| US6515004B1 (en) * | 1999-12-15 | 2003-02-04 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| US6534531B2 (en) * | 2000-04-27 | 2003-03-18 | Bristol-Myers Squibb Company | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| SI21099A (sl) * | 2000-07-26 | 2003-06-30 | Bristol-Myers Squibb Company | N-(5-(((5-alkil-2-oksazolil)metil)tio)-2-tiazolil) karboksamidni inhibitorji ciklin odvisnih kinaz |
-
2007
- 2007-06-06 JP JP2009514368A patent/JP2009539846A/ja active Pending
- 2007-06-06 EP EP07795829A patent/EP2044066A2/en not_active Withdrawn
- 2007-06-06 WO PCT/US2007/013384 patent/WO2007146039A2/en active Application Filing